|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.85 EUR | -5.51% |
|
-10.23% | +20.50% |
| 06-05 | ZEISS CLARUS 700 Receives NMPA Approval in China | CI |
| 06-05 | ZEISS CLARUS 700 Receives NMPA Approval in China | RE |
| Capitalization | 4.8B 5.52B 4.51B 4.11B 7.58B 479B 8.57B 53.49B 20.51B 219B 20.7B 20.25B 807B | P/E ratio 2025 * |
30.1x | P/E ratio 2026 * | 23.3x |
|---|---|---|---|---|---|
| Enterprise value | 5.24B 6.02B 4.92B 4.48B 8.27B 522B 9.34B 58.32B 22.37B 239B 22.57B 22.08B 880B | EV / Sales 2025 * |
2.36x | EV / Sales 2026 * | 2.16x |
| Free-Float |
40.86% | Yield 2025 * |
1.1% | Yield 2026 * | 1.52% |
More valuation ratios
* Estimated data
More news
Last Transcript: Carl Zeiss Meditec AG
More recommendations
More press releases
More news
| 1 day | -5.51% | ||
| 1 week | -10.23% | ||
| Current month | -3.60% | ||
| 1 month | -8.81% | ||
| 3 months | -14.23% | ||
| 6 months | +19.76% | ||
| Current year | +20.50% |
| 1 week | 54.85 |  | 62.4 |
| 1 month | 53.7 | | 63.25 |
| Current year | 44.28 | | 71.65 |
| 1 year | 44.28 | | 72.2 |
| 3 years | 44.28 | | 145.95 |
| 5 years | 44.28 | | 202 |
| 10 years | 21.78 | | 202 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2025-05-31 | |
| Director of Finance/CFO | 60 | 2018-09-30 | |
| Chief Operating Officer | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 57 | 2018-04-09 | |
Karl Lamprecht
CHM | Chairman | 61 | 2021-05-26 |
Isabel de Paoli
BRD | Director/Board Member | 51 | 2020-06-24 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 2.71% | 0 M€ | -.--% | - | |
| 0.49% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.51% | -10.23% | -14.90% | -49.10% | 5.54B | ||
| -0.03% | -0.55% | +17.75% | +162.12% | 183B | ||
| +1.36% | -1.21% | -29.53% | -22.52% | 150B | ||
| -0.07% | +1.56% | +30.36% | +179.06% | 150B | ||
| +1.00% | -2.13% | -22.97% | -19.47% | 141B | ||
| +0.72% | +1.27% | -12.81% | +4.29% | 59.43B | ||
| -0.20% | -1.76% | -18.78% | -17.36% | 43.31B | ||
| +0.58% | -4.22% | -21.90% | -27.93% | 38.29B | ||
| +1.12% | +1.74% | +23.25% | +25.89% | 37.13B | ||
| +0.03% | -1.30% | -13.28% | +1.48% | 32.83B | ||
| Average | -0.10% | -1.66% | -6.28% | +23.65% | 83.97B | |
| Weighted average by Cap. | +0.47% | -0.64% | -2.31% | +58.93% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.22B 2.55B 2.08B 1.9B 3.5B 221B 3.95B 24.68B 9.46B 101B 9.55B 9.34B 372B | 2.36B 2.72B 2.22B 2.02B 3.73B 236B 4.22B 26.33B 10.1B 108B 10.19B 9.97B 397B |
| Net income | 158M 182M 149M 136M 250M 15.81B 283M 1.77B 677M 7.24B 683M 668M 26.65B | 207M 237M 194M 177M 326M 20.61B 369M 2.3B 883M 9.44B 891M 871M 34.74B |
| Net Debt | 434M 499M 408M 371M 685M 43.28B 774M 4.83B 1.85B 19.82B 1.87B 1.83B 72.96B | 302M 347M 284M 258M 477M 30.11B 539M 3.36B 1.29B 13.79B 1.3B 1.27B 50.77B |
More financial data
* Estimated data
Employees
5,713
Calendar
08-06
- Q3 2025 Earnings Call
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-20 | 54.85 € | -5.51% | 541,354 |
| 25-06-19 | 58.05 € | -1.86% | 62,110 |
| 25-06-18 | 59.15 € | -1.42% | 159,159 |
| 25-06-17 | 60.00 € | -3.15% | 95,859 |
| 25-06-16 | 61.95 € | +1.39% | 72,257 |
Delayed Quote Xetra, June 20, 2025 at 11:35 am
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
54.85EUR
Average target price
63.50EUR
Spread / Average Target
+15.77%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AFX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition